NEW YORK, April 25, 2018 /PRNewswire/ --
According to a report byOristep Consulting, the global medical cannabis market in 2016 was valued at $12.67 billion and is projected to reach $33.41 billion by 2022 at a CAGR of 17.53% during the forecast period. Various
Earlier this year California has started legal sales of recreational cannabis. While sales are growing, there are concerns that supply will fall short of demand. According to a report by the Chicago Tribune, Charles Boldwyn, chief compliance officer of ShowGrow in Santa Ana, explained, "We're looking at … hundreds of licensed cultivators and manufacturers coming out of an environment where we literally had thousands of people who were cultivating and manufacturing… So the red tape is a bit of a bottleneck in the supply chain." Despite the concerns, the market in California is expected to witness strong growth. The state Department of Finance expects Californians to purchase about 1 million pounds of cannabis over the first full year of legalization, between July 1, 2018, and June 30, 2019.
WeedMD Inc. (OTC: WDDMF) is also listed on the TSX Venture Exchange under the ticker symbol (TSX-V: WMD). Last week the company announced breaking news together with Hiku Brands Company Ltd. (CSE: HIKU) that, "they have entered into a definitive agreement (the "Arrangement Agreement") to merge both companies, creating an industry leader (the "Transaction"). The Transaction combines two highly-complementary businesses and creates a unique and market differentiating vertically integrated company. Upon completion of the Transaction, existing Hiku and WeedMD shareholders will own approximately 51.75% and 48.25% of the combined company, respectively, on a fully-diluted basis. Upon closing of the Transaction, it is anticipated that the common shares of the pro forma resulting entity will be listed on the TSX Venture Exchange ("TSX-V"), subject to regulatory approvals. Joint management will be hosting a conference call on Friday, April 20, 2018 beginning at 10:00AM EST. See end of the press release for details.
The combination of Hiku and WeedMD creates a premium cannabis brand house with fully vertically integrated operations, an expanding network of retail stores, a growing medical business and four scalable cannabis production facilities, two of which are currently licensed. As a result of the Transaction, Hiku will operate a diverse cannabis supply chain that includes a large portfolio of unique genetics for its growing brand portfolio and emerging nationwide retail sales channels. The entity combines Hiku's strength in retail and branding - ensuring a high quality, consistent and educational consumer experience in the adult-use cannabis market - with WeedMD's existing service and quality in the medical market.
"Our vision at Hiku has always been that cannabis is a consumer product - in which brands, retail and customer experience will ultimately win," said Alan Gertner, Chief Executive Officer of Hiku. "The combination of Hiku and WeedMD creates a cannabis company capable of fulfilling the vision of delivering the best in class experiences from in-store to product, from medical to adult-use, but also capturing full retail and wholesale margins. Our combined offerings create a company that is insulated from potential wholesale margin compression and is ready to scale its offering globally."
Bruce Dawson-Scully, Chief Executive Officer of WeedMD, said, "WeedMD was founded on the principles of product and patients first. Our goal since inception has been on procuring world class genetics, cultivating premium medical cannabis, and delivering it with best-in-class service to our valued patient base. We look forward to the next step in WeedMD's journey by merging with Hiku, a complimentary group that furthers our mission by bringing our focus and passion into a more robust platform. Having access to iconic brands and a growing retail footprint to execute on our growth plan together with our cultivation and existing medical expertise is intended to ensure significant benefits to our shareholders and expected to present significant upside as Canada marches towards legalization."
Hiku has built a portfolio of iconic, engaging cannabis brands, immersive retail experiences and handcrafted cannabis production. Hiku is recognized as an early leader in Canada's emerging adult-use market, with the Tokyo Smoke retail banner awarded Brand of the Year at the 2017 Lift Cannabis Awards. In February 2018, Tokyo Smoke, Hiku's wholly owned subsidiary, was awarded one of only four conditional master licenses for cannabis retail in Manitoba, an important milestone in Hiku's Canada-wide cannabis retail expansion plans.
With a retail footprint led by Tokyo Smoke, cannabis production through DOJA's ACMPR licensed facility, and Van der Pop's female-focused educational platforms, Hiku houses an industry-leading portfolio for cannabis in Canada's adult-use market. WeedMD operates a 26,000 square foot indoor facility with over 1,500 kg of current production capacity and is fully funded for a large-scale production expansion of a 14-acre greenhouse on a 98-acre property representing an increase to more than 50,000 kg of capacity. The combined companies create a brand-focused retail business with the ability to provide product quality and selection on par with the retail experience itself.
Highlights of the Transaction:
Organigram Holdings Inc. (OTCQB: OGRMF) is a leading licensed producer of medical marijuana based in Moncton, New Brunswick. Recently, the company announce the yield results from the inaugural harvest in the first of its 23 new, state-of-the-art Phase 2 indoor grow rooms. Beginning on Friday, "4/20" and completed on Saturday, Organigram harvested over 1500 plants from the first room commissioned in the Company's Phase 2 expansion. The first of the 23 new rooms, which began housing plants on February 10th, has reached final stages of flowering for its first crops. Harvests from subsequent rooms will begin this week. Initial yields support the Company's predictions that changes in process efficiencies will result in annual yields higher than initially estimated when Phase 2 was designed. At present, the Company reaffirms its target production capacity from Phases 1 and 2 of approximately 22,000 kg/year (up from initial estimations of 16,000 kg/year). Facility enhancements include a fully-automated irrigation system, automated potting, a fully automated waste destruction system and automated packaging lines, adding to a data-based production approach which ensures growing optimization for every room.
Supreme Cannabis Company, Inc. (OTC: SPRWF) is a Canadian publicly traded company committed to becoming a leading cultivator and distributor of sun grown cannabis through its wholly-owned subsidiary 7ACRES. 7ACRES is a federally licensed producer of medical cannabis pursuant to the ACMPR operating inside a 342,000 sq. ft. Hybrid Facility. The Hybrid Facility combines the best technology of indoor production with the efficiencies and sustainability of a greenhouse, in a single large-format production footprint. In March, the company announced that it has entered into a definitive agreement pursuant to which Supreme Cannabis will complete a C$10,000,000 strategic equity investment in Medigrow. Upon completion of the Investment, Supreme Cannabis will hold an approximate 10% ownership interest in Medigrow. Supreme Cannabis expects strong demand to exceed supply for medical cannabis oil globally and believes Lesotho is well suited to produce quality cannabis oil and Medigrow possesses the expertise to meet the highest quality standards.
THC BioMed Intl Ltd. (OTCQB: THCBF) is an ACMPR Licensed Producer and a supplier of legal Cannabis Genetics. THC also produces and sells dried and fresh marijuana and cannabis oil for medical purposes. THC is also active in scientific research and the development of products and services related to the medical cannabis industry. Earlier this month, the company announced that it will purchase a building in downtown Kelowna. The building consists of two stories and has 8000 sq. feet of space. The building is one of very few buildings based in the downtown Kelowna that is zoned for industrial use. The city of Kelowna permits cannabis production on industrial-zoned land. The purchase price is $1,875,000, plus fees and taxes, for a total of $1,922,273. THC is purchasing the property for cash and will not require a mortgage.
iAnthus Capital Holdings, Inc. (OTCQB: ITHUF) owns and operates best-in-class licensed cannabis cultivation, processing and dispensary facilities throughout the United States. Recently, the company announced the completion of its acquisition of the remaining 20% of Pilgrim Rock Management, LLC, the affiliated management and services company that provides intellectual property licensing, professional and management services, real estate and equipment leasing, and certain other services to Mayflower Medicinals, Inc. ("Mayflower"). Mayflower, a non-profit Massachusetts corporation affiliated with Pilgrim Rock, has received two provisional licenses to operate Registered Marijuana Dispensaries ("RMDs") in Massachusetts, with a third RMD application pending before the Massachusetts Department of Public Health ("DPH"). Following the acquisition, iAnthus now owns 100% of Pilgrim Rock.
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
Media Contact: firstname.lastname@example.org +1-877-601-1879
Subscribe to our Free Newsletters!